RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of Medicine to explore the potential of KYZATREX® (testosterone undecanoate) CIII capsules, an FDA-approved oral testosterone therapy, in improving patient outcomes before and after surgery, critical care, and…